Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-12

Clinical Trial Update: A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2/3 trial evaluating intermittent treatment to prevent malaria in Senegalese children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 2, Phase 3 | Status: COMPLETED